Objective:To examine the safety and effectiveness of a novel domestic transcatheter aortic valve system in addressing severe aortic valve stenosis.Methods:This prospective, multicenter, single-arm target-value clinical trial enrolled patients with severe aortic stenosis meeting inclusion criteria from 13 Chinese centers between July 2021 and April 2022. The primary endpoint was all-cause mortality at 1-year post-procedure. Secondary endpoints included safety outcomes (30-day all-cause mortality, 1-year major adverse cardiovascular events, device success) and efficacy parameters (transvalvular pressure gradient, paravalvular leak severity, New York Heart Association(NYHA)class improvement, and quality of life). Survival analysis was performed using the Kaplan-Meier analysis.Results:The study included 134 patients, 85 males and 49 females, with an age of (73.6±5.6)years (range: 65.1 to 91.8 years). Bicuspid aortic valve morphology was present in 59.7% (80/134). Device success rate was 99.3%, with one case converted to open surgery due to coronary obstruction. All-cause mortality was 0.8% (95% CI: 0.1% to 5.3%) at both 30-day and 1-year follow-up, significantly lower than the 25% target value ( P<0.01). Permanent pacemaker implantation rates remained 2.2% (3/134) at both timepoints. Stroke incidence was 0.7% (1/134) at 30 days and 1.5% (2/134) at 1 year. Myocardial infarction rates were 0.7% (1/134) at both intervals. The postoperative transvalvular pressure gradient of the aortic valve was (6.6±3.1) mmHg(1 mmHg=0.133 kPa) (range: 4 to 8 mmHg). Among the patients, 32 cases (23.9%) had mild paravalvular leakage, 4 cases (3.0%) had moderate paravalvular leakage, and no severe paravalvular leakage was observed. NYHA class Ⅰ and Ⅱ patients increased from 18.7% preoperatively to 99.3% postoperatively. Conclusion:The novel domestic transcatheter aortic valve system demonstrates satisfactory 1-year safety and efficacy outcomes in treating severe aortic stenosis.

Porcine hemagglutinating encephalomyelitis virus(PHEV)is highly prevalent and wide-ly distributed,and its harm on pig farming is of great concern,therefore,effective strategies for prevention and control are necessary.In this study,chloroquine(CQ)was selected and its effect and mechanism on replication and proliferation of PHEV were investigated.The results showed that CQ(1-100 mmol/L)inhibits the replication and proliferation of PHEV in a dose-dependent manner and has no cytotoxicity on N2a cells.The production of inflammatory cytokines and activa-tion of NF-κB signaling pathway were both inhibited by CQ concentration at 50 mmol/L in PHEV-infected N2a cells.In conclusion,we confirmed the inhibition of CQ in replication and proliferation of PHEV.It is expected to be applied to the prevention and treatment of PHEV in clinical.

Porcine hemagglutinating encephalomyelitis virus(PHEV)is one of the coronaviruses susceptible to swine populations.The non-structural protein 2(NS2)encoded by its genome is fre-quently deleted during the epidemic transmission of the virus,but its biological significance re-mains unclear.In order to explore the structure and function of the NS2 protein,this study utilized platforms such as ProtParam,TMHMM,NetPhos3.1,and ExPASy to analyze its physicochemical properties,spatial structure,genetic evolution,and post-translational modification characteristics.Meanwhile,the NS2 protein was expressed in eukaryotes and transcriptome sequencing was per-formed to clarify the biological processes it participates in.The results showed that the NS2 protein consists of 233 amino acids,with a molecular weight of 26.735 kDa,and a half-life of approximately 30 hours in mammals.It includes 13 phosphorylation sites,2 N-glycosylation sites,and 1 O-glyco-sylation site,with no signal peptide and strong hydrophilicity.The a-helix accounts for the highest proportion in NS2(43.78％),followed by random coils(36.05％).The homology of the NS2 pro-tein between the epidemic strains PHEV-CC14 and PHEV-JL/2008 in Northeast China is 99.57％.The NS2 protein is widely involved in the regulation of nerve-related functions,such as axon guid-ance and synaptic development.This study preliminarily clarified the biological function of the NS2 protein,providing a new perspective for understanding the pathogenic mechanism of PHEV.

Porcine hemagglutinating encephalomyelitis virus(PHEV)is one of the coronaviruses susceptible to swine populations.The non-structural protein 2(NS2)encoded by its genome is fre-quently deleted during the epidemic transmission of the virus,but its biological significance re-mains unclear.In order to explore the structure and function of the NS2 protein,this study utilized platforms such as ProtParam,TMHMM,NetPhos3.1,and ExPASy to analyze its physicochemical properties,spatial structure,genetic evolution,and post-translational modification characteristics.Meanwhile,the NS2 protein was expressed in eukaryotes and transcriptome sequencing was per-formed to clarify the biological processes it participates in.The results showed that the NS2 protein consists of 233 amino acids,with a molecular weight of 26.735 kDa,and a half-life of approximately 30 hours in mammals.It includes 13 phosphorylation sites,2 N-glycosylation sites,and 1 O-glyco-sylation site,with no signal peptide and strong hydrophilicity.The a-helix accounts for the highest proportion in NS2(43.78％),followed by random coils(36.05％).The homology of the NS2 pro-tein between the epidemic strains PHEV-CC14 and PHEV-JL/2008 in Northeast China is 99.57％.The NS2 protein is widely involved in the regulation of nerve-related functions,such as axon guid-ance and synaptic development.This study preliminarily clarified the biological function of the NS2 protein,providing a new perspective for understanding the pathogenic mechanism of PHEV.

Porcine hemagglutinating encephalomyelitis virus(PHEV)is highly prevalent and wide-ly distributed,and its harm on pig farming is of great concern,therefore,effective strategies for prevention and control are necessary.In this study,chloroquine(CQ)was selected and its effect and mechanism on replication and proliferation of PHEV were investigated.The results showed that CQ(1-100 mmol/L)inhibits the replication and proliferation of PHEV in a dose-dependent manner and has no cytotoxicity on N2a cells.The production of inflammatory cytokines and activa-tion of NF-κB signaling pathway were both inhibited by CQ concentration at 50 mmol/L in PHEV-infected N2a cells.In conclusion,we confirmed the inhibition of CQ in replication and proliferation of PHEV.It is expected to be applied to the prevention and treatment of PHEV in clinical.

Objective:To examine the safety and effectiveness of a novel domestic transcatheter aortic valve system in addressing severe aortic valve stenosis.Methods:This prospective, multicenter, single-arm target-value clinical trial enrolled patients with severe aortic stenosis meeting inclusion criteria from 13 Chinese centers between July 2021 and April 2022. The primary endpoint was all-cause mortality at 1-year post-procedure. Secondary endpoints included safety outcomes (30-day all-cause mortality, 1-year major adverse cardiovascular events, device success) and efficacy parameters (transvalvular pressure gradient, paravalvular leak severity, New York Heart Association(NYHA)class improvement, and quality of life). Survival analysis was performed using the Kaplan-Meier analysis.Results:The study included 134 patients, 85 males and 49 females, with an age of (73.6±5.6)years (range: 65.1 to 91.8 years). Bicuspid aortic valve morphology was present in 59.7% (80/134). Device success rate was 99.3%, with one case converted to open surgery due to coronary obstruction. All-cause mortality was 0.8% (95% CI: 0.1% to 5.3%) at both 30-day and 1-year follow-up, significantly lower than the 25% target value ( P<0.01). Permanent pacemaker implantation rates remained 2.2% (3/134) at both timepoints. Stroke incidence was 0.7% (1/134) at 30 days and 1.5% (2/134) at 1 year. Myocardial infarction rates were 0.7% (1/134) at both intervals. The postoperative transvalvular pressure gradient of the aortic valve was (6.6±3.1) mmHg(1 mmHg=0.133 kPa) (range: 4 to 8 mmHg). Among the patients, 32 cases (23.9%) had mild paravalvular leakage, 4 cases (3.0%) had moderate paravalvular leakage, and no severe paravalvular leakage was observed. NYHA class Ⅰ and Ⅱ patients increased from 18.7% preoperatively to 99.3% postoperatively. Conclusion:The novel domestic transcatheter aortic valve system demonstrates satisfactory 1-year safety and efficacy outcomes in treating severe aortic stenosis.

Objective:To evaluate the efficacy and safety of a novel domestic pulmonary thromoboectomy system Tendvia TM in the treatment for high-risk patients complicated with acute pulmonary embolization (APE). Methods:The study was designed as a prospective single-center clinical trial. Twenty-four high-risk patients with APE were recruited and underwent percutaneous mechanical thromoectomy (PMT) with the Tendvia TM pulmonary thromoboectomy system. The primary efficacy endpoint was the reduction of RV/LV ratio at the post-operative 48 h. The secondary efficacy endpoints included technical success rate, mean pulmonary arterial pressure (mPAP), arterial PaO 2 and the instant post-operative thrombus clearance rate. The evaluation of the safety included the intraoperative complications and related complications during the follow-up period associated with the PMT operation and the major adverse event (MAE) rate within the post-operative 48 h. The pre-and post-operative data were compared with paired sample t-test or Wilcoxon rank sum test to evaluate the efficacy and safety of Tendvia TM pulmonary thromoboectomy system. Results:The technical success rate of PMT with Tendvia TM pulmonary thromoboectomy system was 100% (24/24). The 48 h pre-operative RV/LV ratio was 1.19±0.25 and the post-operative RV/LV ratio was 0.82±0.16. The mean RV/LV ratio of the patients was decreased by 0.37±0.25 at post-operative 48 h with significant statistical difference ( t=7.03, P<0.001). The 48 h pre-operative mPAP was (31.09±6.09) mmHg and the post-operative mPAP was (25.91±4.36) mmHg. The mPAP of the patients was reduced by 5.18 mmHg at post-operative 48 h with significant statistical difference ( t=6.73, P<0.001). The pre-operative PaO 2 was (74.66±11.28) mmHg and the post-operative PaO 2 was (88.01±10.57) mmHg. The pressure of oxygen in artery was increased by 13.36 mmHg. The differences were statistically significant( t=-4.08, P<0.001). The rate of thrombus removal was 68.17%±22.66%. 87.5% (21 cases) of patients achieved a thrombus removal greater than grade Ⅱ. One patient underwent catheter directed thrombolysis (CDT) after PMT based on the evaluation of operator. The patient′s thrombus removal achieved grade Ⅲ after 48 h and the CDT was ceased. Hemoptysis occurred intra-operatively in one case underwent PMT and the symptom of the patient was alleviated with conservative medication. The MAE incidence within the post-operative 48 h was 4.17% (1/24). No device-related mortality or all-cause mortality occurred in the trial. Conclusions:The Tendvia TM pulmonary thromoboectomy system is a safe and effective device to remove the pulmonary arterial thrombus for the treatment of patients with APE. The Tendvia TM pulmonary thromoboectomy system can be a new choice in the treatment for the patients with APE.

Exoelectrogens are promising for a wide variety of potential applications in the areas of environment and energy, which convert chemical energy from organic matter into electrical energy by extracellular electrons transfer (EET). Microorganisms with different mechanisms and EET efficiencies have been elucidated. However, the practical applications of exoelectrogens are limited by their fundamental features. At present, it is difficult to realize the extensive application of exoelectrogens in complex and diverse environments by means of traditional engineering strategies such as rational design and directed evolution. The exoelectrogens with excellent performance in environments can be screened with efficient strain identification technologies, which promote the widespread applications of exoelectrogens. The aims of this review are to summarize the methods of screening based on different types of exoelectrogens, and to outline future research directions of strain screening.
Bioelectric Energy Sources ; Electricity ; Electron Transport

Objective To investigate the feasibility of constructing tissue engineered heart valve (TEHV) in deeellularized porcine aortic valve scaffolds by seeding endothelial cells (EC) differentiated from human skin fibroblasts (HSF) derived from pluripotent stem cells (iPSc).Methods Primary HSF were isolated from the patient and infected by lentiviral supernatant harboring OCT4, SOX2, KLF4, c-MYC genes.Changes in cell morphology were observed after infection.Alkaline phosphatase (AP) staining,immunofluorescence staining were used to identify the derived HSF-iPSc.Then, HSF-iPSc were differentiated directly in induction medium.The markers of endothelial cells were detected by Western Blot during differentiation.CD31-positive cells were sorted by flow cytometry after differentiation.HSF-iPSc-EC markers were detected by immunofluorescence staining, and HSF-iPSc-EC function was analyzed by phagocytosis assay and tube formation.Decellularized porcine aortic valve scaffolds were prepared and observed by HE staining and scanning electron microscopy.TEHV was constructed by seeding HSF-iPSc-EC on the valve scaffolds and cultured by static-rotary-static model.Morphological characteristics of TEHV were observed by HE staining and scanning electron microscopy.oα-SMA expression levels were detected by immunofluorescence staining.Results Morphology of the reprogrammed HSF was identical to the embryonic stem cells.AP staining was positive, and pluripotency markers of Nanog, SSEA3, SSEA4, Tra-1-60 and Tra-1-81 were expressed positively.The endothelial markers of CD31, VE-cad, vWF, eNOS were up-regulated continually during the differentiation of HSF-iPSc into EC.CD31, VE-cad, vWF, and eNOS were expressed in sorted HSF-iPSc-EC.Meanwhile, HSF-iPSc-EC had obvious acetylated LDL phagocytosis and tube formation capacity.Cells in porcine aortic valve were stripped completely and the reticular structure of fibers remained intact.Endothelial-like cells displayed stratified growth on the surface of the constructed TEHV with good order and adhesion.In addition,the planted HSF-iPSc-EC had the expression of α-SMA with spatial specificity.Conclusions The obtained HSF-iPSc-EC could be used as ideal seed cells for the construction of TEHV, and the goal of reendothelialization in decellularized aortic valve in vitro was realized preliminarily.

Objective To investigate the feasibility of constructing tissue engineered heart valve (TEHV) in deeellularized porcine aortic valve scaffolds by seeding endothelial cells (EC) differentiated from human skin fibroblasts (HSF) derived from pluripotent stem cells (iPSc).Methods Primary HSF were isolated from the patient and infected by lentiviral supernatant harboring OCT4, SOX2, KLF4, c-MYC genes.Changes in cell morphology were observed after infection.Alkaline phosphatase (AP) staining,immunofluorescence staining were used to identify the derived HSF-iPSc.Then, HSF-iPSc were differentiated directly in induction medium.The markers of endothelial cells were detected by Western Blot during differentiation.CD31-positive cells were sorted by flow cytometry after differentiation.HSF-iPSc-EC markers were detected by immunofluorescence staining, and HSF-iPSc-EC function was analyzed by phagocytosis assay and tube formation.Decellularized porcine aortic valve scaffolds were prepared and observed by HE staining and scanning electron microscopy.TEHV was constructed by seeding HSF-iPSc-EC on the valve scaffolds and cultured by static-rotary-static model.Morphological characteristics of TEHV were observed by HE staining and scanning electron microscopy.oα-SMA expression levels were detected by immunofluorescence staining.Results Morphology of the reprogrammed HSF was identical to the embryonic stem cells.AP staining was positive, and pluripotency markers of Nanog, SSEA3, SSEA4, Tra-1-60 and Tra-1-81 were expressed positively.The endothelial markers of CD31, VE-cad, vWF, eNOS were up-regulated continually during the differentiation of HSF-iPSc into EC.CD31, VE-cad, vWF, and eNOS were expressed in sorted HSF-iPSc-EC.Meanwhile, HSF-iPSc-EC had obvious acetylated LDL phagocytosis and tube formation capacity.Cells in porcine aortic valve were stripped completely and the reticular structure of fibers remained intact.Endothelial-like cells displayed stratified growth on the surface of the constructed TEHV with good order and adhesion.In addition,the planted HSF-iPSc-EC had the expression of α-SMA with spatial specificity.Conclusions The obtained HSF-iPSc-EC could be used as ideal seed cells for the construction of TEHV, and the goal of reendothelialization in decellularized aortic valve in vitro was realized preliminarily.